{"context":{"query":">>hgnc>>ensembl>>reactome","source_dataset":"hgnc","target_dataset":"reactome"},"stats":{"queried":7,"total":97,"mapped":4},"pagination":{"has_next":false},"schema":"id|name|tax_id|is_disease_pathway","mappings":[{"input":"HGNC:1527","source":"HGNC:1527|caveolin 1","targets":["R-HSA-163560|Triglyceride catabolism|9606|false","R-HSA-203615|eNOS activation|9606|false","R-HSA-203641|NOSTRIN mediated eNOS trafficking|9606|false","R-HSA-209968|Thyroxine biosynthesis|9606|false","R-HSA-210991|Basigin interactions|9606|false","R-HSA-4641262|Disassembly of the destruction complex and recruitment of AXIN to the membrane|9606|false","R-HSA-5218920|VEGFR2 mediated vascular permeability|9606|false","R-HSA-8980692|RHOA GTPase cycle|9606|false","R-HSA-9009391|Extra-nuclear estrogen signaling|9606|false","R-HSA-9013026|RHOB GTPase cycle|9606|false","R-HSA-9013106|RHOC GTPase cycle|9606|false","R-HSA-9013148|CDC42 GTPase cycle|9606|false","R-HSA-9013149|RAC1 GTPase cycle|9606|false","R-HSA-9013404|RAC2 GTPase cycle|9606|false","R-HSA-9013405|RHOD GTPase cycle|9606|false","R-HSA-9013406|RHOQ GTPase cycle|9606|false","R-HSA-9013407|RHOH GTPase cycle|9606|false","R-HSA-9013408|RHOG GTPase cycle|9606|false","R-HSA-9013409|RHOJ GTPase cycle|9606|false","R-HSA-9013423|RAC3 GTPase cycle|9606|false","R-HSA-9035034|RHOF GTPase cycle|9606|false","R-HSA-9617828|FOXO-mediated transcription of cell cycle genes|9606|false","R-HSA-9696264|RND3 GTPase cycle|9606|false","R-HSA-9696270|RND2 GTPase cycle|9606|false","R-HSA-9696273|RND1 GTPase cycle|9606|false","R-HSA-9735871|SARS-CoV-1 targets host intracellular signalling and regulatory pathways|9606|true","R-HSA-9755779|SARS-CoV-2 targets host intracellular signalling and regulatory pathways|9606|true","R-HSA-109582|Hemostasis|9606|false","R-HSA-1430728|Metabolism|9606|false","R-HSA-162582|Signal Transduction|9606|false","R-HSA-1643685|Disease|9606|true","R-HSA-194138|Signaling by VEGF|9606|false","R-HSA-194315|Signaling by Rho GTPases|9606|false","R-HSA-195721|Signaling by WNT|9606|false","R-HSA-201681|TCF dependent signaling in response to WNT|9606|false","R-HSA-202131|Metabolism of nitric oxide: NOS3 activation and regulation|9606|false","R-HSA-202733|Cell surface interactions at the vascular wall|9606|false","R-HSA-212436|Generic Transcription Pathway|9606|false","R-HSA-4420097|VEGFA-VEGFR2 Pathway|9606|false","R-HSA-556833|Metabolism of lipids|9606|false","R-HSA-5663205|Infectious disease|9606|true","R-HSA-73857|RNA Polymerase II Transcription|9606|false","R-HSA-74160|Gene expression (Transcription)|9606|false","R-HSA-8939211|ESR-mediated signaling|9606|false","R-HSA-8979227|Triglyceride metabolism|9606|false","R-HSA-9006931|Signaling by Nuclear Receptors|9606|false","R-HSA-9006934|Signaling by Receptor Tyrosine Kinases|9606|false","R-HSA-9012999|RHO GTPase cycle|9606|false","R-HSA-9614085|FOXO-mediated transcription|9606|false","R-HSA-9678108|SARS-CoV-1 Infection|9606|true","R-HSA-9679506|SARS-CoV Infections|9606|true","R-HSA-9692914|SARS-CoV-1-host interactions|9606|true","R-HSA-9694516|SARS-CoV-2 Infection|9606|true","R-HSA-9705683|SARS-CoV-2-host interactions|9606|true","R-HSA-9716542|Signaling by Rho GTPases, Miro GTPases and RHOBTB3|9606|false","R-HSA-9824446|Viral Infection Pathways|9606|true"]},{"input":"HGNC:29","source":"HGNC:29|ATP binding cassette subfamily A member 1","targets":["R-HSA-1989781|PPARA activates gene expression|9606|false","R-HSA-5682113|Defective ABCA1 causes TGD|9606|true","R-HSA-8963896|HDL assembly|9606|false","R-HSA-9029569|NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux|9606|false","R-HSA-1430728|Metabolism|9606|false","R-HSA-162582|Signal Transduction|9606|false","R-HSA-1643685|Disease|9606|true","R-HSA-174824|Plasma lipoprotein assembly, remodeling, and clearance|9606|false","R-HSA-382551|Transport of small molecules|9606|false","R-HSA-400206|Regulation of lipid metabolism by PPARalpha|9606|false","R-HSA-556833|Metabolism of lipids|9606|false","R-HSA-5619084|ABC transporter disorders|9606|true","R-HSA-5619115|Disorders of transmembrane transporters|9606|true","R-HSA-8963898|Plasma lipoprotein assembly|9606|false","R-HSA-9006931|Signaling by Nuclear Receptors|9606|false","R-HSA-9024446|NR1H2 and NR1H3-mediated signaling|9606|false"]},{"input":"HGNC:14193","source":"HGNC:14193|Rho guanine nucleotide exchange factor 12","targets":["R-HSA-193648|NRAGE signals death through JNK|9606|false","R-HSA-416482|G alpha (12/13) signalling events|9606|false","R-HSA-416572|Sema4D induced cell migration and growth-cone collapse|9606|false","R-HSA-8980692|RHOA GTPase cycle|9606|false","R-HSA-9013026|RHOB GTPase cycle|9606|false","R-HSA-9013106|RHOC GTPase cycle|9606|false","R-HSA-9013148|CDC42 GTPase cycle|9606|false","R-HSA-1266738|Developmental Biology|9606|false","R-HSA-162582|Signal Transduction|9606|false","R-HSA-193704|p75 NTR receptor-mediated signalling|9606|false","R-HSA-194315|Signaling by Rho GTPases|9606|false","R-HSA-204998|Cell death signalling via NRAGE, NRIF and NADE|9606|false","R-HSA-372790|Signaling by GPCR|9606|false","R-HSA-373755|Semaphorin interactions|9606|false","R-HSA-388396|GPCR downstream signalling|9606|false","R-HSA-400685|Sema4D in semaphorin signaling|9606|false","R-HSA-422475|Axon guidance|9606|false","R-HSA-73887|Death Receptor Signaling|9606|false","R-HSA-9012999|RHO GTPase cycle|9606|false","R-HSA-9675108|Nervous system development|9606|false","R-HSA-9716542|Signaling by Rho GTPases, Miro GTPases and RHOBTB3|9606|false"]},{"input":"HGNC:2597","source":"HGNC:2597|cytochrome P450 family 1 subfamily B member 1","targets":["R-HSA-211976|Endogenous sterols|9606|false","R-HSA-2142670|Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)|9606|false","R-HSA-2142816|Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)|9606|false","R-HSA-5579000|Defective CYP1B1 causes Glaucoma|9606|true"]}],"not_found":["HGNC:7610","HGNC:4169","HGNC:6654"]}